Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all... see more

Recent & Breaking News (TSXV:PCLO)

PharmaCielo to Participate in 2020 Cowen Boston Cannabis Conference

Canada NewsWire November 13, 2020

PharmaCielo Begins Harvest of High-THC Cultivars for Extract Export

Canada NewsWire November 5, 2020

PharmaCielo Announces Upsizing of Private Placement Offering

Canada NewsWire November 3, 2020

PharmaCielo Ltd. Expands Board Depth and Expertise with Appointment of Marc Lustig as Lead Director and Strengthens Capital Position with Private Placement Offering

Canada NewsWire November 2, 2020

PharmaCielo to Participate in Cantor Fitzgerald Latin America Cannabis Seminar

Canada NewsWire October 23, 2020

Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite

Canada NewsWire October 6, 2020

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2020 and Provides Operational Update

Canada NewsWire August 31, 2020

PharmaCielo to Hold Conference Call to Review Second Quarter 2020 Financial Results

Canada NewsWire August 18, 2020

PharmaCielo Increases Cannabis Cultivation Through External Contractor to Meet Market Demand for Medicinal Extracts

Canada NewsWire August 13, 2020

PharmaCielo Announces Results of AGM

Canada NewsWire August 7, 2020

PharmaCielo Receives Colombian Government Authorization for 10 Tonnes of High-THC Cultivation and Extract Production for Export

Canada NewsWire July 8, 2020

PharmaCielo Ltd. Closes $4.6 Million Bought Deal Offering

Canada NewsWire July 3, 2020

PharmaCielo Ltd. Files Final Prospectus for $4 Million Bought Deal Offering

Canada NewsWire June 29, 2020

PharmaCielo Ltd. Announces $4,000,000 Bought Deal Public Offering

Canada NewsWire June 10, 2020

PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2020 and Provides Operational Update

Canada NewsWire June 1, 2020

PharmaCielo Ltd. Obtains Final Receipt for Short Form Prospectus

Canada NewsWire May 15, 2020

PharmaCielo Welcomes Dr. Claudia Jiménez to Board of Directors

Canada NewsWire May 12, 2020

PharmaCielo Adds Experienced Senior Leader to Executive Team

Canada NewsWire May 4, 2020

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2019

Canada NewsWire April 30, 2020

PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call

Canada NewsWire April 29, 2020